Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 688M | 682M | 665M | 646M |
Cost of revenue | 155M | 158M | 157M | 155M |
Gross profit | 533M | 524M | 508M | 491M |
Operating expense | ||||
Research & development | 154M | 157M | 158M | 164M |
Selling general and admin | 340M | 348M | 366M | 346M |
Other operating expenses | — | — | — | — |
Operating income | 39M | 19M | -16M | -19M |
Non operating interest income | ||||
Income | 30M | 24M | 26M | 29M |
Expense | 1M | 1M | 1M | 1M |
Other income expense | — | -11M | 16M | 3M |
Pretax income | 68M | 31M | 25M | 12M |
Tax provision | 6M | 8M | 9M | -17M |
Net income | 62M | 23M | 16M | 29M |
Basic EPS | 0.4 | — | 0.1 | 0.2 |
Diluted EPS | 0.4 | — | 0 | 0.2 |
Basic average shares | 174.2M | — | 170.2M | 168.6M |
Diluted average shares | 181.8M | — | 170.7M | 174.4M |
EBITDA | 93M | 67M | 32M | 27M |
Net income from continuing op. | 62M | 23M | 16M | 29M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |